1. MARKETS
  2. SECTOR : PHARMACEUTICALS & BIOTECHNOLOGY
  3. INDUSTRY : BIOTECHNOLOGY
  4. BIOCON LTD.
Biocon Ltd. NSE: BIOCON | BSE: 532523
Strong Performer, Getting Expensive
Download real time
394.85 -1.00 (-0.25%)
35.69% Gain from 52W Low
5.4M
NSE+BSE Volume

NSE 26 Feb, 2026 3:31 PM (IST)

Watchlist

Portfolio

Alert
US FDA Approval
Biocon gets US FDA nod for its Liraglutide injection, with a market size of $127 mn in 2025 See details

Biocon - BIOCON - stock price prediction, stock forecast, target price, analyst ratings from 19 analysts

Biocon has a share price target of Rs 424, revenue growth forecast of 11.8%, and profit growth estimate of -46.2% for FY26, based on top 19 analyst calls.

Forecaster Screeners